Fluoroquinolone antibiotics
Some commonly used brand names include: Cipro, Floxin, Maxaquin, Noroxin, Penetrex. Ciprofloxacin, (Ciloxan, Ciproxin), Enoxacin, Lomefloxacin, Norfloxacin, (Utinor), Ofloxacin (Tarivid) Before Using This Medication
More information: Please read the information included in FDA announcements about disbling adverse side-effects. Click here for UK Support Group for those harmed by fluoroquinolone toxicity Patient Safety Advocate Rachel Brummert has a new web site www.rachelbrummert.com Rachel's previous web site is still worth browsing for information about fluoroquinolone antibiotics European Medicines Agency Public Hearing on Quinolone and Fluoroquinolone Medicines Personal experiences from people across the EU heard at the EMA evidence session June 2018 Levofloxacin Convulsions and toxic psychoses have been reported in patients receiving quinolonas, including levofloxacin. Quinolones may also cause increased intracranial pressure and central nervous system stimulation that may lead to tremors, restlessness, anxiety, lightheadedness, confusion, hallucinations, paranoia, depression, nightmares, insomnia, and rarely suicidal thoughts or acts. These reactions may occur following the first dose. If these reactions occur in patients receiving levofloxacin, the drug should be discontinued and appropriate measures instituted. As with other quinolones, levofloxacin should be used with caution in patients with a known or suspected CNS disorder that may predispose to seizures or lower the seizure threshold (e.g., severe cerebral arteriosclerosis, epilepsy)or in the presence of other risk factors that my predispose to seizures or lower the seizure threshold (e.g., certain drug therapy, renal dysfunction.) The following events were considered likely to be drug-related in patients receiving multiple doses of levofloxacin: insomnia 0.3%, malaise 0.1%, nervousness 0.1%, sleep disorders 0.1%, tremor 0.1%. In clinical trials, the following events occurred in 1 to 3% of patients, regardless of drug relationship: insomnia 2.9%, dizziness 2.5%. The following adverse events occurred in clinical trials at a rate of 0.5 to less than 1%, regardless of drug relationship: agitation, anxiety, fatigue, nervousness, somnolence. Abnormal coordination, abnormal dreaming, aggressive reaction, anaemia, confusion, convulsions (seizures), emotionally lability, hallucination, impaired concentration, manic reaction, mental deficiency, sleep disorders, speech disorder, stupor... Abnormal thinking, agitation, anxiety, arthalgia, confusion, convulsion, depersonalization, depression, euphoria, hallucination, hostility, nervousness, panic attack, paranoia, psychosis, taste loss. Convulsions, increased intracranial pressure, and psychosis have been Quinolones may also cause central nervous system (CNS) stimulation, which may lead to tremors, restlessness, lightheadedness, confusion, hallucinations, paranoia, depression, nightmares, and insomnia. These reactions may occur following the first dose. Avelox / Moxifloxacin Nonsteroidal anti-inflammatory drugs (NSAIDs): Although not observed with Convulsions have been reported in patients receiving quinolones. Quinolones may also cause central nervous system (CNS) events including: dizziness, These reactions may occur following the first dose. If these reactions occur in patients receiving moxifloxacin, the drug should be discontinued and appropriate measures instituted. Cipro Ciprofloxacin Less than 1 percent:Central Nervous System: Convulsive seizures, paranoia, toxic psychosis, depression, dysphasia, phobia, depersonalization, manic reaction, unresponsiveness, ataxia, confusion, hallucinations, dizziness, lightheadedness, paresthesia, anxiety, tremor, insomnia, nightmares, weakness, drowsiness, irritability, malaise, lethargy. Convulsions, increased intracranial pressure, and toxic psychosis have been reported in patients receiving quinolones, including ciprofloxacin. Ciprofloxacin may also cause central nervous system (CNS) events including: dizziness, confusion, tremors, hallucinations, depression, and, rarely, suicidal thoughts or acts.These reactions may occur following the first dose. If those reactions occur in patients receiving ciprofloxacin, the drug As with all quinolones, ciprofloxacin should be used with caution in patients with known or suspected CNS disorders that may predispose to seizures or lower the seizure threshold (e.g., severe cerebral arteriosclerosis, epilepsy), or in the presence of other risk factors that may predispose to seizures or lower the seizure threshold
Be aware of interactions with other medicines.. Reporting Adverse Drug Reactions (ADRs) Please report Adverse Drug Reactions (ADRs) to: UK Yellow Card Reporting for Patient and Health Professional reports of Adverse Drug Reactions USA and worldwide to the Food and Drug Administration for Patients and Healthcare Professionals Universal free, independent drug safety website - Rxisk/ For latest news read the APRIL blog Please follow APRIL on Twitter
AWARENESS SAVES LIVES
|